MedTrace Logo

Circulating Tumor Cells Spillage After Pulmonary Biopsy

NCT02507778 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-09-23

No results posted yet for this study

Summary

The aim of this study is to quantify the spillage of tumor cells after biopsy in early lung cancer.

Conditions

Interventions

DEVICE

CellCollectorTM (Gilupi, Germany) needle

needle will be inserted before and after biopsy and will measure circulating tumor cells.

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-09-30
Completion
2019-09-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02507778 on ClinicalTrials.gov